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Intercalated diskThe cardiac sodium current (INa) is responsible for the rapid depolarization of cardiac cells, thus allowing for
their contraction. It is also involved in regulating the duration of the cardiac action potential (AP) and prop-
agation of the impulse throughout the myocardium. Cardiac INa is generated by the voltage-gated Na+ chan-
nel, NaV1.5, a 2016-residue protein which forms the pore of the channel. Over the past years, hundreds of
mutations in SCN5A, the human gene coding for NaV1.5, have been linked to many cardiac electrical disorders,
including the congenital and acquired long QT syndrome, Brugada syndrome, conduction slowing, sick sinus
syndrome, atrial ﬁbrillation, and dilated cardiomyopathy. Similar to many membrane proteins, NaV1.5 has
been found to be regulated by several interacting proteins. In some cases, these different proteins, which re-
side in distinct membrane compartments (i.e. lateral membrane vs. intercalated disks), have been shown to
interact with the same regulatory domain of NaV1.5, thus suggesting that several pools of NaV1.5 channels
may co-exist in cardiac cells. The aim of this review article is to summarize the recent works that demon-
strate its interaction with regulatory proteins and illustrate the model that the sodium channel NaV1.5 resides
in distinct and different pools in cardiac cells. This article is part of a Special Issue entitled: Cardiomyocyte
Biology: Cardiac Pathways of Differentiation, Metabolism and Contraction.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The contraction of cardiac cells is triggered by the fast and long-
lasting electrical depolarization of the membrane, called the action
potential (AP). Among the many different ionic currents that are in-
volved in generating the cardiac AP, the cardiac sodium current (INa)
plays a central role in the early depolarization of the AP, the duration
of the AP, and the propagation of the electrical impulse from one cell
to the other [23]. The main voltage-gated sodium channel expressed
in cardiac cells is NaV1.5 [26] (Fig. 1A), which is the pore-forming pro-
tein of about 220 kDa, also called α-subunit. It has been shown to
assemble with small (about 30–40 kDa), single trans-membrane seg-
ment proteins called β-subunits [8]. Four of these β-subunits have
been found to be encoded in the human genome [8].
Since 1995, hundreds of mutations in SCN5A, the human gene cod-
ing for NaV1.5, have been linked to many cardiac electrical disorders,
including the congenital and acquired long QT syndrome, Brugada
syndrome, conduction slowing, sick sinus syndrome, atrial ﬁbrilla-
tion, and dilated cardiomyopathy [75]. This long list of allelic diseases
clearly underlines the central role of NaV1.5 in normal physiology andcyte Biology: Cardiac Pathways
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l rights reserved.diseases, but also raises the question as to whether or not this channel
may have, as of yet, unrecognized functions. Similar tomanymembrane
proteins, NaV1.5 has been found to be regulated by several interacting
proteins [1]. For some of these cases, these different proteins, which
reside in speciﬁc subcellular regions of the cardiomyocyte (i.e. lateral
membrane vs. intercalated disks), have been shown to interact with
the same regulatory domain of NaV1.5, thus suggesting that several
pools of NaV1.5 channels may co-exist in cardiac cells. Mutations in
the genes coding for several of these partner proteins were found
in patients with inherited arrhythmias, such as congenital long QT
syndrome (LQTS) [11] and Brugada syndrome (BrS) [46]. The pro-
teins interacting with NaV1.5 can act as: anchoring/adaptor proteins
involved in trafﬁcking, targeting, and anchoring of the channel pro-
tein to speciﬁc membrane compartments; as enzymes interacting
with and modifying the channel structure via post-translational
modiﬁcations (e.g. protein kinases or ubiquitin ligases); and as pro-
teins modulating the biophysical properties of NaV1.5 upon binding
(Table 1).
In this review article, we ﬁrst describe the proteins that interact with
NaV1.5. These interacting proteins were discovered either by performing
protein–protein interaction screens, such as yeast two-hybrid assays, or
by using proteomic-based protein identiﬁcation assays. The sites of inter-
action, often protein–protein interaction modules, were mapped on the
sequence of NaV1.5 as described in Fig. 1A. Second, wewill review the ex-
perimental evidence obtained recently that suggest that NaV1.5 is part of
distinct pools in cardiomyocytes.
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NaV1.5 interacts with several partner proteins that regulate the
channel's biology and function [1]. Speciﬁc regions of NaV1.5 have
been identiﬁed as essential for these interactions.
2.1. Associated proteins that interact with the C-terminal domain of NaV1.5
The 243-residue, intracellular C-terminal part of NaV1.5 contains sev-
eral protein–protein interaction motifs [2]. The most well-characterized
interaction sites are a calmodulin-binding IQmotif, a PYmotif, and a PDZ
domain-binding motif.
2.1.1. Proteins interacting with the PDZ domain-binding motif
PDZ domains are conserved domains that interact with the
carboxy-terminal ends of target proteins. PDZ is the acronym for
PSD-95 (post-synaptic density protein), DlgA (the Drosophila
disks-large tumor suppressor protein), and ZO-1 (the tight junction
protein, zonula occludens-1). This domain has been identiﬁed in a
variety of proteins that are often found in structures at the plasma
membrane and are involved in signal transduction pathways [60].
The last three residues of the NaV1.5 C-terminus (Ser–Ile–Val, SIV)
constitute the SIV-motif that interacts with PDZ domain-bearing
proteins that contain a class I PDZ-domain (i.e. a domain that recog-
nizes the C-terminal –Ser/Thr-X-ψ-Val sequence, where X is any
amino acid and ψ is any hydrophobic amino acid) [20]. Several pro-
teins such as PTPH1, SAP97, and syntrophins have been described to
interact with this PDZ domain-binding motif.
Gee and co-workers ﬁrst investigated the possibility that
syntrophins bind to voltage-gated sodium channels via their PDZ
domains [25]. They were able to co-purify a complex formed by so-
dium channels, syntrophins, and dystrophin from extracts of skel-
etal and cardiac muscle. Peptides corresponding to the last 10
amino acids of the NaV1.4 and NaV1.5 C-terminus were sufﬁcient
to inhibit the binding of native sodium channels to syntrophin
PDZ domain fusion proteins and to bind speciﬁcally to PDZ domainsFig. 1. Topology of NaV1.5 and its interaction with various regulatory proteins. The pore-form
together by intracellular and extracellular loops. Each of these domains contains segments th
sensor segment (S4). Several regulatory proteins for NaV1.5 were identiﬁed and their sites
these interactions are shown to take place at the intracellular loops or the C-terminus of N
associate with NaV1.5, the sites of interaction on the NaV1.5 channel are still unknown.from α1, β1, and β2-syntrophin. Using yeast two-hybrid and gluta-
thione S-transferase (GST) pull-down experiments, Ou and
co-workers showed that the PDZ domain of syntrophin γ2 directly
interacts with the C-terminus of NaV1.5. They investigated the func-
tional consequences of this interaction [51] and found that
co-expression of syntrophin γ2with NaV1.5 shifted the steady-state ac-
tivation of the sodium current (INa). In a later study, our group demon-
strated that NaV1.5 interacts with dystrophin via syntrophins. In
dystrophin-deﬁcient mouse hearts, the protein level of NaV1.5 was
decreased, resulting in a reduced cellular INa and conduction defects
that suggest that dystrophin regulates the expression level of NaV1.5
[24].
The second protein reported to interact with the PDZ domain-
bindingmotif of NaV1.5 is protein tyrosine phosphatase (PTPH1), a pro-
tein expressed inmany different tissues, including the heart [30]. In this
work, our group showed that co-expression of PTPH1 with NaV1.5
shifted the availability of sodium channels towards hyperpolarized
potentials and that this effect was abrogated when the C-terminal SIV
motif of NaV1.5 was mutated. With this observation that more than
one protein can interact with the same motif (SIV), it was proposed
that NaV1.5 may be part of different multi-protein complexes, depending
upon the membrane compartment to which it is located.
More recently, we demonstrated in human atria and mouse ventri-
cles, a speciﬁc interaction between the PDZ domain-binding motif of
NaV1.5 and a major membrane associated guanylate kinase (MAGUK)
scaffolding protein, SAP97 [53]. Immunostainings performed on rat
heart sections showed that NaV1.5 and SAP97 are both co-localized at
intercalated disks, and electrophysiological studies demonstrated that
sodium currents were reduced in rat atrial myocytes, infected with
shRNA-containing lentiviruses. Silencing of endogenous SAP97 expres-
sion in HEK293 cells, which were transiently transfected with NaV1.5,
resulted in reduced sodium current. The current recorded in SAP97-
silenced cells was comparable to the ones recorded in cells that were
transfected with NaV1.5 channels lacking the last three amino acids
(the SIV motif) of the C-terminus. Surface expression of NaV1.5 was de-
creased in silenced cells which may underlie the reduced currenting alpha subunit of NaV1.5 consists of four homologous domains (DI-DIV), connected
at contribute to the lining of the channel pore (segments S5 and S6) as well as a voltage
of interaction have been mapped on the alpha subunit of the NaV1.5 channel. Many of
aV1.5. For a few proteins that have been shown (through co-immunoprecipitation) to
Table 1
Table 1 summarizing the 17 proteins (or families of proteins) that have been reported to interact with and regulate Nav1.5. Note that this table does not take into account the four
beta sodium channel subunits.
Protein Main effects on NaV1.5 Motif on NaV1.5 Swissprot Reference
number
References
Syntrophin proteins Adapt to dystrophin and utrophin complex and
stabilization at the lateral membrane of the
myocytes
PDZ domain-binding motif in
C-terminus
Q13424
(SNTA1_HUMAN)
[3,24,25]
SAP97 Trafﬁcking and anchoring to the cell membrane PDZ domain-binding motif in
C-terminus
Q12959
(DLG1_HUMAN)
[53]
Ankyrin-G Targeting to the cell membrane VPIAxxSD motif in intracellular loop
DII-III
Q12955
(ANK3_HUMAN)
[34,47]
MOG1 Involved in trafﬁcking to the cell membrane Intracellular loop between DII-III Q9HD47
(MOG1_HUMAN)
[77]
α-Actinin-2 Involved in trafﬁcking to the cell membrane Intracellular loop between DIII-IV P35609
(ACTN2_HUMAN)
[83]
Desmoglein-2 Overexpression of ARVC mutant in mice reduces INa Not determined Q14126
(DSG2_HUMAN)
[57]
Plakophilin-2 Silencing reduces INa, shifts negatively steady-state
inactivation, and slows recovery from inactivation
Not determined Q99959
(PKP2_HUMAN)
[63]
Protein-tyrosine-phosphatase-H1 Phosphorylation and modulation of biophysical
activity
PDZ domain-binding motif in
C-terminus
P26045
(PTN3_HUMAN)
[30]
Nedd4-like E3 ubiquitin ligases Ubiquitylation and internalization PY-motif in C-terminus Q96PU5
(NED4L_HUMAN)
[59,68]
Calmodulin kinase II c Phosphorylation and modulation of biophysical
activity
Intracellular loop between DI-II and via
βIV-spectrin
Q13557
(KCC2D_HUMAN)
[5,28,72]
FGF proteins Modulation of gating kinetics and density at cell
membrane
Residues 1773–1832 in
C-terminus
Q92913
(FGF13_HUMAN)
[38,73]
Calmodulin Many discrepant effects but may confer
intracellular
calcium sensitivity to NaV1.5
IQ-motif (1900–1920) in
C-terminus and Loop III-IV
P62158
(CALM_HUMAN)
[17,32,55,65,80]
14-3-3η (eta) Modulation of steady-state inactivation Intracellular loop between DI-II Q04917
(1433F_HUMAN)
[4]
Caveolin-3 Mutant of caveolin-3 induces persistent current Not determined P56539
(CAV3_HUMAN)
[16,70]
GPD1-L Mutant variants decrease INa in heterologous
expression system
Not determined Q8N335
(GPD1L_HUMAN)
[39,69]
Telethonin Modulation of voltage dependence of activation Not determined O15273
(TELT_HUMAN)
[43]
ZASP Mutant of ZASP shifts steady-state
activation towards positive potentials
Not determined O75112
(LDB3_HUMAN)
[36]
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NaV1.5, Kir2.1, and SAP97 are part of the samemacromolecular complex
[45]. Using a multidisciplinary approach, they showed that IK1–INa inter-
actions involve a reciprocal modulation of expression of their respective
channel proteins (Kir2.1 and NaV1.5). Moreover, SAP97 may affect the
integrity of the complex or the nature of NaV1.5–Kir2.1 interactions.
Thus, it has been shown that at least three PDZ domain-bearing
proteins, syntrophin proteins, SAP97, and PTPH1, may interact with
the PDZ domain-binding motif of NaV1.5. In our most recent work, we
provided evidence for the co-existence of at least two pools of NaV1.5
channels in cardiomyocytes, one located at the lateral membrane with
the dystrophin multiprotein complex, and the other localizing speciﬁ-
cally with the MAGUK protein SAP97 at the intercalated disks [52].
The speciﬁc roles and their possible distinct regulatory functions still
have yet to be understood and will be discussed later in this review.
2.1.2. PY-motif
Many different ion channels have been reported to be regulated via
ubiquitylation, a post-translational modiﬁcation that allows the target
proteins to be degraded or transported to other membrane compart-
ments. Proteins which have consensus domains known as PY motifs,
with the sequence [L/P]PxY, are known to bind speciﬁcally to members
of the Nedd4-like family of E3 ubiquitin-protein ligases. Suchmotifs are
found in the C-termini of all voltage-gated sodium channels, with the
exception of NaV1.4, NaV1.9 and NaX (a concentration-sensitive sodium
channel which structurally resembles voltage-gated sodium channels).
Our group reported that the ubiquitin-protein ligase, Nedd4-2, directly
binds to the PY motif of NaV1.5 and ubiquitylates the channel inmammalian cells. We also found that in cardiac tissue, NaV1.5 can be
regulated by ubiquitylation [68]. In the paper by Rougier et al. it was
conﬁrmed that Nedd4-2 increases the internalization rate of NaV1.5
channels that are expressed in HEK293 cells [59].
2.1.3. IQ-motif
The “IQ motif,” with the consensus sequence of IQxxxRxxxxR at
the C-terminal domain of NaV1.5, constitutes a calmodulin (CaM)-
binding motif. CaM is a ubiquitous Ca2+-binding protein, involved
in many different cellular processes [14]. Different studies have
reported a direct interaction of CaMwith the IQmotif of NaV1.5, howev-
er, the functional consequences of this interaction show many incon-
sistent results (e.g. decreased, increased, or unmodiﬁed steady-state
inactivation and entry into slow inactivation of NaV1.5) that are difﬁcult
to reconcile [17,65,80]. These inconsistencies could be due to differ-
ences in species, expression systems, or experimental protocols used.
Nevertheless, many results suggest that intracellular calcium is an
important regulator of NaV1.5 function.
2.1.4. Other interaction sites at the C-terminus
The interactions of other proteins with the C-terminus of NaV1.5
have been described, even if the precise motifs involved in NaV1.5 reg-
ulation were not yet identiﬁed. Certain ﬁbroblast growth factor homol-
ogous factors (FHF) family members such as FHF1B (also known as
FGF12) and FGF14, can interact with a region of the C-terminus of
NaV1.5 (aa 1773–1832), and modulate gating kinetics of the cardiac
sodium channel in heterologous expression systems [27,38,40]. More
recently, it was shown that speciﬁc FGF13 isoforms are the major
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NaV1.5 C-terminus (as demonstrated by co-immunoprecipitation and
pull-down experiments using the C-terminal amino acids 1773–2018
of NaV1.5 fused to GST). Immunostainings of isolated adult mouse ven-
tricular myocytes showed that FGF13 co-localizes with NaV1.5 at the
lateral membrane and intercalated disks. Silencing of FHF13 in mouse
ventricular myocytes revealed that FGF13 modulates cardiac NaV1.5
channel function and membrane expression, leading to changes in car-
diac conduction properties.
Thus, numerous modulatory proteins can bind to the long
C-terminal region of NaV1.5 and play a critical role in membrane
targeting and functioning of the channel. However, the question of
whether these different partners work in concert with each other
still remains to be investigated.
2.2. Associated proteins interacting with the intra- or extracellular loops
of NaV1.5
2.2.1. Loop DI-DII
The DI-DII linker segment of NaV1.5 is a region that possesses
many sites of phosphorylation [58].
In 2006, Allouis and co-workers demonstrated that 14-3-3η, a dimeric
cytosolic adaptor protein, interacts with the N-terminal portion (residues
417 to 467 of NaV1.5) of the intracellular loop that links domain I to do-
main II [4]. From immunostainings of rabbit adult cardiomyocytes, they
showed that NaV1.5 and 14-3-3η co-localize at the intercalated disks.
Moreover, 14-3-3η was able to modify the biophysical properties of
NaV1.5 channels when co-expressed in COS cells.
In addition to the multiple PKA and PKC phosphorylation sites
described in the DI-II loops of NaV channels, it has been shown that
NaV1.5 is phosphorylated and regulated by CaMKII, a serine/threonine
protein kinase that transduces an intracellular Ca2+ increase into phos-
phorylation of multiple proteins [72,79]. CaMKII is expressed in cardiac
tissue where it co-localizes and co-immunoprecipitates with NaV1.5.
Recently Ashpole et al. showed that CaMKIIδc interacts with the ﬁrst in-
tracellular loop of NaV1.5 and that the residues Ser-516 and Thr-594
may be phosphorylated by this kinase [5]. CaMKII inhibition causes a
negative shift in sodium current steady-state inactivation, a delayed
recovery from slow inactivation, and thus leads to a drastic reduction
in the upstroke velocity of action potentials [79]. Over-expression of
the predominant cardiac isoformCaMKIIδ increases the persistent inward
sodium current and prolongs the QRS duration [72]. Moreover, Hund and
co-workers identiﬁed a CaMKII/βIV-spectrin/ankyrin-G/NaV1.5 complex
at the intercalated disk of mouse cardiomyocytes [28]. They proposed
thatβIV-spectrin exerts spatial control over CaMKII-dependent regulation
of voltage-gated Na+ channels at the intercalated disk.
2.2.2. Loop DII-DIII
Two proteins have been identiﬁed that interact with the II-III link-
er segment of NaV1.5: ankyrin G and MOG-1. In 2003, Lemaillet and
co-workers showed that a nine-amino-acid-long sequence that was
found in the II-III linker segment of all NaVs (1047-VPIAVAESD-1055,
NaV1.5 numbering) interacts with ankyrin-G [34]. Ankyrin proteins
organize, transport, and anchor ion transporters to the actin and
spectrin cytoskeleton. Expression of ankyrin-B and ankyrin-G has
been demonstrated in the heart, but even though NaV1.5 channels
display a late opening in ankyrin-B knock-out mouse myocytes,
there is no evidence of a direct interaction with ankyrin-B [12].
Concerning the role of ankyrin-G, Mohler and co-workers proposed
that this protein not only acts as an anchoring protein for NaV1.5,
but also controls trafﬁcking and sorting of the channel [47].
The second protein reported to interact with the intracellular loop
between domain II and III of NaV1.5 is MOG1 (multi-copy suppressor
of gsp1). MOG1 is a small 29-kDa protein found in the nucleus and
the cytosol of cardiac cells. The interaction between NaV1.5 and MOG1
was described byWu and co-workers, using a yeast two-hybrid screen,followed by pull-downs with a GST-NaV1.5-LII fusion protein and
co-immunoprecipitation experiments [77]. Co-expression of MOG1
and NaV1.5 in HEK293 cells led to increased INa as well as increased
cell surface expression of NaV1.5, suggesting that MOG1 is a co-factor
for optimal expression of the channel at the cell membrane. In mouse
ventricular myocytes, the two proteins were shown to co-localize at
the intercalated disks.
2.2.3. Loop DIII-DIV
A member of the superfamily of F-actin cross-linking proteins,
α-actinin-2, was identiﬁed as an interacting partner of the NaV1.5 cy-
toplasmic loop that connects domains III and IV [83]. Immunostaining
experiments showed that α-actinin-2 co-localized with NaV1.5 along
the Z-lines and in the plasma membrane. Co-immunoprecipitation
and pull-down assays conﬁrmed the physical association of these
proteins and showed that the spectrin-like repeat domain (amino
acids 87–390) is essential for the binding of α-actinin-2 to NaV1.5.
Functionally, this interaction increases sodium channel density with
no change in gating properties.
Another proteinwas also found to interactwith the DIII-DIV loop. As
mentioned previously, the C-terminus of NaV1.5 contains an IQ-motif,
thus enabling its binding with calmodulin. Recently, Potet and co-
workers also described a direct physical interaction of CaMwith speciﬁc
domains within the C-terminus and the DIII-DIV linker, both of which
inﬂuence the inactivation of NaV1.5. This suggests a coupling of these
two domains via CaM [55]. This latter CaM-interacting sequence in
NaV1.5 is not completely mapped, but amino acids 1520-FIF-1522 and
1494-YY-1495 seem important for the interaction [55,61].
2.2.4. Associated proteins that interact with the extracellular loops of NaV1.5
To our knowledge, only the β1-subunit has been proposed to inter-
act with the connecting loop between S5 and S6 of D1 and DIV in NaV
channels [42]. The β1, β2, and β3-subunits have been shown to
co-immunoprecipitate withNaV1.5 in cardiacmyocytes and transfected
HEK cells [19,67]. However, while β-subunits have been reported to as-
sociate with NaV1.5 and modulate NaV1.5 surface expression and chan-
nel gating, current data are sometimes conﬂicting, mainly depending
upon the expression systems/species used for the study [21,33,44,81].
2.3. Associated proteins that interact with the N-terminal domain of NaV1.5
The role of the N-terminal region of NaV1.5 in cardiac sodium
channel function has not been fully elucidated and, to our knowledge,
no protein has been reported yet that interacts with this region of the
channel. A few studies have attempted to identify interacting proteins
with the N-terminus of NaV1.5 (e.g. Poon and co-workers who found
that the annexin II light chain p11 binds to NaV1.8, on amino acids
74–103, but not to sodium channels isoforms NaV1.2, 1.5, 1.7 or 1.9)
[54]. Recently, O'Brien and co-workers identiﬁed a new partner that
interacts with the N-terminus of the sodium channel NaV1.6: the
light chain of microtubule associated protein Map1b [49]. Through
co-immunoprecipitation studies they demonstrated the interaction
between endogenous NaV1.6 channels and Map1b in mouse brains.
However, the critical amino acid sequence VAVP (residues 77–80)
that is involved in this interaction is not found in the N-terminus of
NaV1.5.
More recently, Clatot and co-workers [15] demonstrated the impor-
tant role of the N-terminal domain of NaV1.5 in a study where they
examined two Brugada syndrome mutations (R104W and R121W) at
evolutionarily conserved residues in the N-terminal cytoplasmic region
of NaV1.5, and a cDNA construct where this regionwas deleted (ΔNter).
In their study, missense mutations in the N-terminus of NaV1.5 led to
retention and degradation of most of the channel with a dominant-
negative effect on the WT channel protein, while truncation of the
N-terminus did not prevent the channel from reaching the cell surface.
Although the dominant-negative effect of mutant N-terminal NaV1.5
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through direct interaction between NaV1.5 α-subunits, since co-
immunoprecipitation experiments showed that NaV1.5-subunits
interacted with each other, even when mutated [15]. Moreover, co-
expression of a peptide fragment encoding the NaV1.5 N-terminus
and the full WT channel led to a 2-fold increase of INa density com-
pared to the WT channel alone.
2.4. Associated proteins that interact with NaV1.5 at unknown sites
A variety of different proteins that can directly or indirectly interact
with NaV1.5 and functionally regulate this channel has been described.
2.4.1. Caveolin-3
Caveolin-3 is an important component of caveolae (small invagina-
tions of the plasma membrane) where a variety of signaling molecules
and ion channels is enriched [76]. In rat cardiomyocytes it has been
shown that voltage-gated sodium channels associate with caveolin-
rich membranes that were obtained by detergent-free buoyant density
separation. By using indirect immunoﬂuorescence and immunogold
transmission electron microscopy, sodium channels were found to
colocalize with caveolar membranes [78]. Moreover, sodium channels
were found to co-immunoprecipitate with caveolin-3, but not caveolin-
2. The authors also showed that β-adrenergic stimulation by isoprotere-
nol led to a rapid increase of sodium peak current, whichwas completely
abolished by anti-caveolin-3 antibodies. In heterologous expression sys-
tems, NaV1.5 was also found to co-immunoprecipitate with caveolin-3.
In addition, co-expression of NaV1.5 and mutants of caveolin-3 that
were found in long-QT syndrome patients showed an increase in the
inward persistent sodium current [16,70].
2.4.2. GPD1-L
By studying amissensemutation of the gene coding for the glycerol-
3-phosphate dehydrogenase-like protein (GPD1L), which is associated
with Brugada syndrome, London and co-workers found that this pro-
tein is abundant in the heart and can modulate NaV1.5 function [39].
Co-expression experiments showed thatmutant GPD1L reduced the so-
dium current in HEK293 cells. GPD1-L does not appear to directly asso-
ciate with NaV1.5, but the A280V mutation affects NaV1.5 channel
density at the cell surface as well as the number of functional channels.
2.4.3. Plakophilin-2
Mechanical continuity between cardiomyocytes is provided by des-
mosomes and adherens junctions. Plakophilin-2 is a protein found in
the desmosomes of the intercalated disks of cardiac cells. By performing
pull-down experiments, it was demonstrated by Delmar's group that
NaV1.5 interacts with plakophilin-2 [63]. While the nature of the inter-
action (direct or indirect) is still to be determined, they showed that
both proteins are co-localized at the intercalated disk, and that silencing
of plakophilin-2 in cultured cardiomyocytes alters the properties of the
sodium current and the velocity of action potential propagation.
2.4.4. Desmoglein-2
More recently, another protein found in the desmosomes, was
demonstrated to interact with NaV1.5 [57]. Using a mouse model of
arrhythmogenic right ventricular cardiomyopathy, the authors
showed that overexpression of mutant Desmoglein-2 (Dsg2-N271S)
led to a slowed cardiac conduction, stemming from a reduced action
potential velocity and a reduction of the cardiac sodium current.
Moreover, co-immunoprecipitation experiments demonstrated an
interaction between NaV1.5 and both wild-type and mutant Dsg2.
2.4.5. Telethonin
Telethonin is a small 19-kDa protein, known to interact with the
sarcomeric protein titin [48]. Telethonin has been shown to co-
precipitate with NaV1.5 from mouse cardiac tissue, and the two proteinswere found to co-localize in cardiomyocytes [43]. Knockdown of endoge-
nous telethonin inHEK293 cells thatwere stably transfectedwith SCN5A,
led to a shift towards positive potential values of the sodium current
voltage-dependent activation. Overexpression of telethonin also altered
several of the biophysical properties of the sodium channels.
2.4.6. ZASP
The Z-band-alternatively spliced-PDZ motif protein (ZASP) has an
important role in maintaining Z-disk stability in cardiac and skeletal
muscles [82]. ZASP contains a PDZ domain at its N-terminus, which
interacts with the C-terminus of α-actinin-2 [22]. By studying a ZASP
missense mutation, S196L, in a mouse model of cardiomyopathy, Li
and co-workers showed that both INa and ICa,L were altered in the mu-
tant mice [36]. S196L shifted the onset and peak currents of the I-V re-
lationships of INa, which were associated with a shift of the voltage-
dependency of steady-state activation. Moreover, using His-tagged
ZASP4 in pull-down experiments, the authors suggested that ZASP is
part of a protein complex that includes both CaV1.2 and NaV1.5, al-
though it is unclear whether this interaction is direct or indirect. They
also found that both WT and ZASP-S196L remained colocalized with
CaV1.2 and NaV1.5 at the Z-band in mouse cardiomyocytes.
2.5. NaV1.5-associated proteins and pathophysiology
Mutations in the SCN5A gene, as well as variants in the genes
encoding for different subunits and regulatory proteins that interact
with NaV1.5, have been linked to many arrhythmia syndromes [1][72].
This is the case for mutations in all 4 β-subunit-encoding genes that
have been found in individuals with various arrhythmic phenotypes
(cardiac conduction disease, atrial ﬁbrillation, Brugada syndrome, con-
genital long QT syndrome). Mutations in GPD1-L, caveolin-3, α1-
syntrophin, and most recently MOG1 [50] and desmoglein-2 [57], that
are found in patientswith arrhythmia, have also been described to func-
tionally modulate NaV1.5. For other NaV1.5-associated proteins, no
disease-related mutations have been identiﬁed. However, for several
mutations found in NaV1.5 regions that interact with such regulatory
proteins, it has been shown that the interaction between NaV1.5 and
the relevant protein is modiﬁed, thus leading to distinct cardiac pheno-
types [1].
3. Multiple pools of NaV1.5 channels within the cardiomyocyte
3.1. The NaV1.5 “two pools” model
The expression and distribution of the NaV1.5 channel within the
cardiomyocyte have been for some time, a subject of debate, since
immunostainings from early studies had described an exclusive local-
ization of NaV1.5 at the intercalated disks [41]. Current data, however,
contradict this exclusivity of expression, as NaV1.5 has been shown to
be expressed both at the intercalated disks and the lateral membrane
region of the cardiomyocyte [6,51,71]. In addition, recent evidence
has not only reafﬁrmed the more global presence of NaV1.5 within
the cardiomyocyte membrane, but also revealed its distinct organiza-
tion into regulatory multiprotein complexes, where it interacts with
different proteins at various speciﬁc subcellular regions of the cell
membrane.
The ﬁrst indications of the existence of multiple “pools” of NaV1.5
began with studies that investigated the regulatory signiﬁcance of the
PDZ domain-binding motif (SIV motif) of the NaV1.5 channel [24].
Pull-down experiments of human atrial appendages, using GST-fusion
proteins containing wildtype or truncated (ΔSIV) versions of the NaV1.5
C-terminus, ﬁrst revealed that NaV1.5 interacts, via the SIV motif, with
the dystrophin–syntrophin macromolecular complex that localizes spe-
ciﬁcally to the lateral membrane region of the cardiomyocyte [24]. Previ-
ous studies on dystrophin expression have described its presence at the
lateral membrane and its absence at the intercalated disks [31,64].
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leagues showed that dystrophin and syntrophin interact with NaV1.5 to
anchor the channel to the membrane [25]. Disruption of this complex in
dystrophin-deﬁcient mdx mice led to a signiﬁcant 50% reduction in
NaV1.5 protein expression with a corresponding 30% decrease in sodium
current density and conduction defects that manifested in a prolonged
QRS interval in ECG recordings [24]. Thus, correct expression and function
of NaV1.5 channels at the lateral membrane is dependent upon its associ-
ation with dystrophin and syntrophin. This was conﬁrmed in follow-up
studies by Petitprez and colleagues that described co-localization of dys-
trophin/syntrophin with NaV1.5 only at the lateral membranes of
cardiomyocytes and a loss of NaV1.5 immunostaining speciﬁcally at the
lateral membrane (and not in the intercalated disks) of dystrophin-
deﬁcient mdx cardiomyocytes [53]. Optical mapping of these mutant
mouse hearts displayed signiﬁcant slowing of conduction velocities that
were in line with the previous abnormal ECG readings (indicative of con-
duction defects), thus suggesting a signiﬁcant role of the NaV1.5 lateral
membrane pool and its regulation in the proper conduction in the heart.
More importantly, the Petitprez et al. study is a clear demonstration
of the existence of at least two distinct pools of NaV1.5 that are differen-
tially regulated at separate sub-cellular regions of the cardiomyocyte
andwhich both contribute to normal impulse propagation and conduc-
tion [51]. Alongwith their evidence for speciﬁc NaV1.5 regulation by the
dystrophin/syntrophin complex at the lateral membrane, this study
also revealed the SAP97 MAGUK protein as a potential regulatory part-
ner of NaV1.5 channels at the intercalated disks. SAP97 is a member of
the Membrane Associated Guanylate Kinase family of proteins that are
involved in anchoring and clustering of ion channels andmembrane re-
ceptors to the cell surface. Pull-down experiments, with both mouse
heart lysates and human atrial tissue, displayed an interaction between
SAP97 andNaV1.5 thatwas SIVmotif-dependent; and immunostainings
of NaV1.5 and SAP97 in ventricular rat heart tissue indicated that this as-
sociation takes place solely at the intercalated disks [51]. The functional
relevance of the SAP97/NaV1.5 interaction was examined by shRNA
SAP97 silencing experiments that resulted in signiﬁcant decreases in
sodium current density in both HEK cells expressing NaV1.5 and cul-
tured rat cardiomyocytes [51]. Mechanistically, this was attributed to
the disruption of interaction of NaV1.5 and SAP97 and subsequently, a
loss of stability and expression at the cell membrane, since biotinylation
experiments revealed a reduction in NaV1.5 cell surface expression.
Taken together, these results have identiﬁed two major interactions
with NaV1.5, located at different sub-cellular regions, which contribute
to cardiac cellular physiology. Further studies (e.g. a ΔSIVmousemodelFig. 2. Representative schematic of the NaV1.5 multiple pools model. Recent ﬁndings from o
ferent sub-cellular domains of the cardiac cell: (left) at the lateral membrane where it intera
the MAGUK protein SAP97. Note that when dystrophin is absent, utrophin can act as a com
other studies to associate with other regulatory proteins at the intercalated disk that are invo
(Cx43).and a SAP97 knock-outmousemodel) continue to investigate the regu-
latory signiﬁcance of the different pools on the function of NaV1.5 and
its consequences in cardiac function.
It was also shown that a compensatory mechanism exists within
the speciﬁc NaV1.5 lateral membrane pool. Utrophin, a homologue
of dystrophin, was found to interact with NaV1.5 in the same manner
as dystrophin (by binding to the SIV motif via the syntrophin adaptor
protein) [3]. However, an upregulation of utrophin was observed in
dystrophin-deﬁcient mdx mice, suggesting that when dystrophin is
lacking, utrophin may compensate for its loss [3]. Double knock-out
mice, lacking both dystrophin and utrophin, showed decreases in
NaV1.5 protein levels, cell surface expression, sodium current density,
and maximal AP upstroke velocity that were more pronounced than
the deﬁcits from dystrophin-deﬁcient mdx mice alone [3]. It would
also be interesting to examine whether potential compensatory
mechanisms for NaV1.5 exist in other pools of NaV1.5 and whether
some of these mechanisms have the ability to crosstalk between the
different sub-cellular domains of the cardiomyocyte and compensate
for deﬁciencies caused by one pool or the other.3.2. Cardiac pathophysiology and the NaV1.5 lateral membrane pool
Since this most recent study from Petitprez et al. [51], several
other studies have been published that support the “multiple pools”
model. Immunostainings of cardiomyocytes from mice, homozygous
for a human D1275N mutation in SCN5A, revealed a loss of NaV1.5 ex-
pression speciﬁcally at the lateral membrane, with retention of ex-
pression in the intercalated disks [74]. These mice not only showed
decreases in NaV1.5 protein level and sodium current (as well as in-
creases in late sodium current and action potential duration), but
also displayed a dilated cardiomyopathy phenotype, as well as ar-
rhythmias and conduction defects, similar to a patient carrying this
mutation. Although the exact mechanism of action affected by this
mutation was not investigated in this study, nevertheless, it corre-
lates loss of expression of NaV1.5 at the lateral membrane to function-
al cellular and clinical phenotypes.
It can also be recalled from past studies that, upon examination of
isolated dog cardiomyocytes that were taken from regions close to in-
farcted areas, Boyden and colleagues had found that the decreases in
sodium current density were accompanied by a speciﬁc loss of NaV1.5
at the lateral membrane, thus suggesting that speciﬁc regulation of
this pool of NaV1.5 channels may play a role in cardiac pathologies [6].ur group suggest that NaV1.5 resides in distinct macromolecular complexes at two dif-
cts with the dystrophin/syntrophin complex; and (right) at the intercalated disks with
pensatory molecule at the lateral membranes. In addition, NaV1.5 has been shown by
lved in stabilization and targeting (AnkG), cell adhesion (pkp2), and electrical coupling
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Functional studies to examine the differences in NaV1.5 electrical
properties at distinct sub-cellular locations were performed through
macropatch experiments at different regions of the rat ventricular
cardiomyocyte (lateral membrane or intercalated disk). The Delmar
group provided evidence for the existence of two distinct NaV1.5
pools with differing biophysical properties [37]. They found that the
fraction of TTX-resistant NaV1.5 channels at lateral membrane regions
displayed a smaller sodium peak current amplitude than those from
the intercalated disks, with a negative shift in steady-state inactiva-
tion and a slower recovery time until reactivation. These experiments
somewhat contradict the results of Verkerk and colleagues which
suggest that TTX-resistant NaV1.5 channels at the lateral membrane
do not exist [71]. The discrepancy in the results, however, may be
due to species-speciﬁc differences since the studies by Verkerk and
colleagues were made using rabbit cardiomyocytes [52].
Lin and colleagues proposed that a possible reason for the functional
differences between the two NaV1.5 “pools” could be due to the associ-
ation of NaV1.5 with different proteins that uniquely regulate it within
speciﬁc regions of the cardiomyocyte [37]. This hypothesis is in agree-
ment with the results from Petitprez et al. [53] that show differential
regulation of NaV1.5 through interaction with various associating pro-
teins at the lateral membrane vs. intercalated disk.
In terms of electrical activity of the cardiac cell, Lin and colleagues
came to the conclusion that most of the NaV1.5 lateral membrane
channels are in the inactivated state at resting membrane potential
compared to NaV1.5 channels at the intercalated disks, thus placing
the burden of excitation on the NaV1.5 channels at the intercalated
disks [37]. This interpretation raises the question of how lateral mem-
brane NaV1.5 channel function integrates with that of the intercalated
disk during action potential propagation, since recent studies men-
tioned above have clearly shown that lateral membrane NaV1.5 chan-
nels can contribute to impulse propagation and conduction. However,
its precise functional role and effect (separate from NaV1.5 intercalat-
ed disk channels) in both normal as well as pathological diseased con-
ditions remain to be further elucidated. Although the signiﬁcance of
these functional differences among the different pools of NaV1.5
channels in the context of action potential propagation still remain
to be further investigated (i.e. through macropatch experiments on
dystrophin-deﬁcient mdx cardiomyocytes or from cardiac cells from
other pathological conditions), these results conﬁrm the existence
of functional NaV1.5 channels at the lateral membrane with different
current properties from those of the intercalated disks.
3.4. Regulation of NaV1.5 at the intercalated disks
It has also been shown inmany studies that the pool of NaV1.5 chan-
nels at the intercalated disk depends upon interactions with key pro-
teins involved in cell-cell communication and electrical coupling.
Studies from the Kléber group examined the effects of Cx43 ablation
on the electrical properties of gap junctions and NaV1.5 channels in cul-
tured atrialmyocytes and founddecreases in electrical conductance and
sodium current that were accompanied by changes in the connexin
composition of these gap junctions [18]. These results underline the sig-
niﬁcance of gap junction remodeling in the modulation of the
sodium current at the intercalated disks, especially during pathological
conditions where Cx43 expression is diminished.
Other recent studies by Jansen and colleagues examined the impact
on functional expression of NaV1.5 and susceptibility to arrhythmias
when the levels of Cx43 were drastically reduced to less than 5% in
mouse ventricular myocytes [29]. In contrast to non-arrhythmogenic
mice, Cx43 knockdown mouse hearts with ventricular arrhythmias re-
vealed a larger reduction of Cx43 expression, along with an increase in
heterogeneity of its expression pattern [29]. These changes correspondedto decreased NaV1.5 protein expression and slower, more dispersed con-
duction, thus indicating that downregulation of both Cx43 andNaV1.5 ex-
pression leads to changes in conduction that increase the vulnerability of
the heart for arrhythmias [29]. Separate experiments within this study,
using cultured Cx43-deﬁcient cardiomyocytes, showed decreases in sodi-
um current, which suggest that NaV1.5 function depends on Cx43 expres-
sion. However, as mentioned in the recent editorial by Remme [56],
functional in vivo evidence to demonstrate the actual causal relationship
of NaV1.5 and Cx43 remain to be further investigated (i.e. whether Cx43
directly or indirectly affects NaV1.5 function), since the inﬂuence of
many other factors such as distribution patterns and sub-cellular local-
ization of proteins in a functional integrated myocardium cannot be
addressed from an in vitro system [56].
Interestingly, Remme [56] also raises several questions regarding
Cx43 regulation of NaV1.5 which are relevant to this current discussion
of multiple pools of NaV1.5 channels: in particular, 1)whether Cx43 can
indirectly regulate the NaV1.5 lateral membrane pool (i.e. through sec-
ondary signaling effects during normal physiological conditions) and
2) whether redistribution of Cx43 to lateral membranes during patho-
logical conditions can subsequently affect the functional expression of
the NaV1.5 lateral membrane pool. As previously mentioned, these
questions, as well as more unanswered ones, await further investiga-
tions, for example, through studies with in vivo mutant models and
macropatch experiments of sodium current in cardiomyocytes that
are mutant for Cx43 and/or NaV1.5.
As mentioned above, a recent study by Sato and colleagues also
revealed that function of NaV1.5 channels at the intercalated disks also
depends upon its associationwith the desmosomal protein, plakophilin
2 [61]. When this interaction was abolished in shRNA-pkp2 silencing
experiments, this resulted in changes in the kinetics of the sodium cur-
rent that led to a decrease in sodium current amplitude and a corre-
sponding decrease in conduction velocity [61]. Optical mapping
studies also detected reentrant activity in pkp2-silenced cells [63]. Sub-
sequent investigations by Sato and colleagues also unveiled a complex-
ity of interaction between gap junctions, desmosomes, and the NaV1.5
channel complex through the interactions of Cx43, pkp2, and ankyrin-
G (AnkG), the cytoskeletal adaptor protein and essential component
of the NaV1.5 complex at the intercalated disk [60]. Here, they demon-
strated that, in AnkG-shRNA silenced cardiomyocytes, loss of AnkG
expression affects the distribution of pkp2 and the expression of Cx43
that result in disruption of cell contacts and a reduction in electrical cou-
pling [62,63]. Taken together, these collective ﬁndings by Sato and col-
leagues integrate the regulation of electrical coupling and cell adhesion/
communicationwith sodium channel expression and function at the in-
tercalated disks.
3.5. A possible third pool of NaV1.5?
Althoughwe have so far identiﬁed two different pools of NaV1.5, our
“multiple NaV1.5 pools”model is not limited to just two distinct NaV1.5
regional populations. In fact, both previous and recent evidence have
shown that NaV1.5 expression is also present at the T-tubules and that
it could possibly represent a third pool for NaV1.5. There is clear func-
tional evidence for the existence of a T-tubule pool of NaV1.5 based
upon de-tubulating experiments which revealed a 22% contribution of
cardiac sodium current from the T-tubule region [9,10]. Furthermore,
many recent studies have also shown immunostainings of NaV1.5
with a T-tubular pattern of expression [47] and [35]. In a recent study
fromMilstein and colleagues that suggested a role for the SAP97 protein
in facilitating the reciprocal regulation of NaV1.5 and the Kir2.1 channel,
they show that NaV1.5 is co-localized with SAP97, both at the T-tubules
as well as the intercalated disks [45]. However, the degree of contribu-
tion of either or both of these pools to the reciprocal regulation of
NaV1.5 and Kir2.1 would be an interesting topic to further investigate.
Collectively, these results are consistent with our stainings of
NaV1.5 at the T-tubules of mouse cardiomyocytes in both WT and
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that this “third” pool does not depend on syntrophin/dystrophin
since it is clearly present in dystrophin-deﬁcientmdx cardiomyocytes.
Thus, this potential third NaV1.5 pool may represent another unique
and separate protein complex (or protein complexes) that monitor
and regulate the correct functional output of sodium current to inﬂu-
ence proper electrical activity and conduction in the normal function-
ing heart.
4. Conclusions and perspectives
The cell biology of cardiac cells, in particular the mechanisms un-
derlying the biosynthesis, trafﬁcking, targeting, and anchoring of ion
channels, is a fascinating and complex topic [7]. Partly because of its
involvement in genetically-determined arrhythmias [1], the cardiac
sodium channel NaV1.5 has been the focus of many investigations.
In this article, we have reviewed recent experimental ﬁndings that il-
lustrate two important concepts. First, NaV1.5, similar to other mem-
brane proteins, is part of multi-protein complexes that are important
for its correct localization and function in cardiac cells; and second,
there is now clear evidence that NaV1.5 is found in different mem-
brane compartments, thus forming distinct pools of channels (Fig. 2).
There is not “one” cardiac sodium channel NaV1.5 with its associated
proteins, but different populations of channels in the different cellular
compartments [53]. At present, very little is known about the speciﬁc
roles that these distinct pools of NaV1.5 may have in the physiology of
the cardiomyocyte. Recent ﬁndings from our group suggest that the
NaV1.5 channels located at the lateral membrane are involved in im-
pulse propagation, since in the case of their reduction in dystrophin-
deﬁcient myocytes [53], a clear slowing of cardiac conduction was ob-
served. Another intriguing observation is the fact that mutations in
the gene coding for α1-syntrophin were found to increase the late INa
that is generated by NaV1.5 [13,66]. However, since α1-syntrophin is
only expressed at the lateral membrane of cardiac cells [53], this sug-
gests a speciﬁc role of lateral membrane NaV1.5 in pathologies associat-
ed with increased late current, such as LQTS. It is clear, however, that a
lot still remains to be deciphered in the future in order to understand
the details of the roles of the multiple pools of NaV1.5 cardiac sodium
channels. These future studies may help us to understand the multiple
pathological phenotypes associated with mutations of SCN5A that are
found in patients with cardiac disorders.
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